Related Experiment Videos
Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2
1Molecular Immunology Group, Nuffield Department of Clinical Medicine, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Nature
|June 5, 1997
Summary
The CD8 glycoprotein binds to MHC class I molecules, stabilizing T-cell interactions. Crystal structure reveals CD8alpha(alpha) binding to HLA-A2, influencing T-cell receptor recognition.
Area of Science:
- Immunology
- Structural Biology
- Biochemistry
Background:
- CD8 glycoprotein is essential for cytotoxic T cell selection.
- CD8 (homodimer CD8alpha(alpha) or heterodimer CD8alpha beta) stabilizes T-cell receptor (TCR) interactions with MHC class I/peptide complexes.
- CD8 binding to MHC class I molecules enhances TCR recognition.
Purpose of the Study:
- To determine the crystal structure of the CD8alpha(alpha) and human MHC molecule HLA-A2 complex.
- To elucidate the molecular interactions between CD8alpha(alpha) and HLA-A2/peptide.
- To understand how CD8 binding affects TCR-peptide-MHC interactions.
Main Methods:
- X-ray crystallography at 2.7 A resolution.
- Structural analysis of the CD8alpha(alpha)-HLA-A2/peptide complex.
Main Results:
- The crystal structure reveals CD8alpha(alpha) binds to a single HLA-A2/peptide molecule.
- CD8alpha(alpha) interfaces with HLA-A2's alpha2 and alpha3 domains and contacts beta2-microglobulin.
- A flexible loop in the HLA-A2 alpha3 domain is clamped by CD8 subunits, preventing secondary MHC binding and altering alpha3 domain positioning.
- These structural changes modulate affinity but do not alter the MHC/peptide surface for TCR recognition.
Conclusions:
- CD8 binding to MHC class I involves specific structural interactions.
- The CD8-MHC interaction contributes to avidity in TCR-peptide-MHC recognition.
- Structural insights provide a basis for understanding T cell activation and immune response.